MedicarePartD.guide

A non-government resource built from CMS public data

adalimumab biosimilars on Humana Basic Rx Plan (S5884-144)

adalimumab-adaz, -fkjp, -aacf and others

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 0.2 per 28 days.

$345.25
Patient pays / month, after deductible
$806.50
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

ADALIMUMAB 10 mg/.1mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,380.98 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
ADALIMUMAB 80 mg/.8mL Injection, Solution5$2,055.03PA · 4.8 per 28 days
ADALIMUMAB 40 mg/.4mL Injection, Solution5$1,208.43PA · 2.4 per 28 days
ADALIMUMAB 40 mg/.4mL Injection, Solution5$1,233.02PA · 2.4 per 28 days
ADALIMUMAB 20 mg/.2mL Injection, Solution5$822.01PA · 1.2 per 28 days
ADALIMUMAB 10 mg/.1mL Injection, Solution5$345.25PA · 0.2 per 28 days

Other TNF blockers on this plan

Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5884-144